Articles for tag: AU SFB, AU SFB share price, BIOCON, BIOCON share price, biosimilar, KPIT TECHNOLOGY, KPIT TECHNOLOGY share price, legal challenges, SONA BLW, SONA BLW share price, एयू एसएफबी, केपीआईटी टेक्नोलॉजी, बायोकॉन, सोना बीएलडब्ल्यू

Strategy for earning from Biocon, AU SFB, Sona BLW, and KPIT Technology: Insights from analysts

HSBC has initiated coverage on Biocon with a “Reduce” rating, establishing a target price of ₹300 per share. This assessment comes in light of recent developments concerning the U.S. launch of a biosimilar to Eylea, a key ophthalmic medication. The anticipated launch of Yesafili, Biocon’s own biosimilar, has faced delays due to legal battles, making ...